Log has written
TUESDAY, NOVEMBER 24, 2009
More articles by: By C.H. Unnikrishnan
  
By C.H. Unnikrishnan  12:02 AM | January 10,2008
Novartis is still challenging Indian patent laws after the first patent application it filed for the drug which was a beta crystal form, was rejected by the Chennai patent office in 2006
By C.H. Unnikrishnan  10:37 AM | January 07,2008
This follows the Centre’s directive to pull out those drug brands that had been cleared without proper tests
By C.H. Unnikrishnan  10:51 PM | December 12,2007
USFDA could approve Glenmark’s generic version for the local market if the company wins the court case
By C.H. Unnikrishnan  01:14 AM | September 12,2007
A Swedish industry delegation representing some 20 top companies in sectors such as construction, power, engineering is visiting India scouting for partners
By C.H. Unnikrishnan  12:04 AM | August 29,2007
It is also supplied in a disposable pen device that can be used for up to 28 days to in once-a-day
By C.H. Unnikrishnan and Jeetha D’Silva  02:20 PM | July 03,2007
Many drug companies have two-track approach to the same drugs because of lack of stringent quality controls and big differences in Indian versus overseas profit margins
By C.H. Unnikrishnan & Jeetha D’Silva  07:10 PM | May 30,2007
The ICMR guidelines prepared in 2000 have little legal binding on drug companies and investigators
By C.H. Unnikrishnan and Jeetha D’Silva  07:03 PM | May 29,2007
Clinical trials involve the testing of a new drug on humans after successfully proving that the chemical or bio-pharmaceutical has the potential to cure a disease or control a disorder
By C.H. Unnikrishnan and Bhuma Shrivastava  07:26 PM | May 08,2007
Some 9,000 heart patients estimated to have had the tiny plastic-and-chromium pipe inserted into their clogged cardiac arteries will have little recourse under Indian law
By C.H. Unnikrishnan   12:39 AM | March 16,2007
The company will be the first specialist drug discovery company to be listed on the Indian stock exchanges
By C.H. Unnikrishnan  12:35 AM | March 15,2007
The facility will employ 400 scientists and focus on 10 key therapeutic areas the company is researching
By C.H. Unnikrishnan  12:15 AM | March 14,2007
The number of brands will go up as local players such as UB and SAB Miller prepare to face the challenge
By C.H. Unnikrishnan  12:07 AM | March 12,2007
The Tata Group company has already developed relevant technologies for biodiesel extraction and refining
By C.H. Unnikrishnan  12:36 AM | February 22,2007
RIL has ambitious plans for the biofuels business and is cultivating Jatropha, a plant that can yield high quality biodiesel, in a 200-acre plot at Kakinada in Andhra Pradesh